Detalles de la búsqueda
1.
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Br J Cancer
; 122(10): 1461-1466, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32210365
2.
Sleep disorders and health-related quality of life in patients with interstitial lung disease.
Sleep Breath
; 22(2): 393-400, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038949
3.
Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-naïve asthmatic patients.
J Asthma
; 54(5): 520-529, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27686218
4.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(6): 822-835, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27132212
5.
SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString).
Future Oncol
; 11(7): 1027-36, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25804118
6.
Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.
Antimicrob Agents Chemother
; 58(3): 1315-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24323477
7.
Interleukin-8 and interleukin-17 for cancer.
Cancer Invest
; 32(5): 197-205, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24669909
8.
Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practice.
Support Care Cancer
; 22(8): 2177-83, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24652050
9.
Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
Respirology
; 19(5): 748-54, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24889556
10.
Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.
Future Oncol
; 9(8): 1171-94, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23902248
11.
Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.
Future Oncol
; 9(4): 505-25, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23560374
12.
Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.
Future Oncol
; 9(9): 1307-13, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23980678
13.
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.
Lancet Respir Med
; 11(1): 74-86, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36252599
14.
Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.
Int J Mol Sci
; 13(9): 10828-10862, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23109824
15.
Long-term respiratory follow-up of H1N1 infection.
Virol J
; 8: 319, 2011 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21702977
16.
Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.
Biomed Pharmacother
; 122: 109461, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31918262
17.
Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis.
Technol Cancer Res Treat
; 18: 1533033819842586, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079574
18.
Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective, randomized trial.
J Thorac Dis
; 11(5): 1788-1798, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31285871
19.
Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study.
Anticancer Res
; 38(6): 3735-3744, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848736
20.
Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice.
Ther Adv Med Oncol
; 10: 1758835918768238, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29662549